Quick Answer
Semnur Pharmaceuticals, Inc. reported Total Assets of $1.35 million for the year ending 2025.
- Semnur Pharmaceuticals, Inc. showed a decrease of -79.9% in Total Assets from 2024 to 2025.
- This data is from Semnur Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $441.9 thousand | Q2 2022: $85.53 million | Q3 2022: $85.76 million | Q1 2023: $86.96 million | Q2 2023: $88.19 million | Q3 2023: $90.15 million | Q1 2024: $51.35 million | Q2 2024: $52.12 million | Q3 2024: $8.92 million | Q1 2025: $9.15 million | Q2 2025: $562.5 thousand | Q3 2025: $774.0 thousand.
- Over the full 4 years of available data (2022 to 2025), Semnur Pharmaceuticals, Inc.'s Total Assets has declined by 98.4%.
- Historical annual values: Fiscal year 2025: $1.35 million | Fiscal year 2024: $6.68 million | Fiscal year 2023: $50.69 million | Fiscal year 2022: $86.28 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: